PANCREAS NEWS
![]()
Article in PDF format - JOP Home page
JOP. J Pancreas (Online) 2006; 7(1):92-93.
Probiotics and Severe Acute Pancreatitis
Raffaele Pezzilli, Lorenzo Fantini
Department of Internal Medicine, Sant’Orsola-Malpighi Hospital. Bologna, Italy
Severe acute pancreatitis is frequently associated with necrosis of the gland, and the principal late complication is infection of the necrosis. The gut barrier plays an important role in severe acute pancreatitis; in fact, gut barrier integrity prevents bacteria translocation resulting from an atrophic and leaky gut, and reduces the systemic inflammatory syndrome of the pancreatitis from gut atrophy. The maintenance of gut barrier integrity is one of the goals in the treatment of severe acute pancreatitis. For this reason, enteral nutrition has been proposed for restoring and preventing morphological changes in the gut associated with fasting. Even if it is quite difficult to demonstrate the effectiveness of nutritional support in patients with severe pancreatitis, some studies are available which illustrate the usefulness of this nutritional measure both in reducing the complications of severe acute pancreatitis [1, 2, 3] and those resulting from infections related to other nutritional measures such as total parenteral nutrition [1]. After these initial studies, others were published using different "immunoactive" formulas such as glutamine [4] and omega 3 fatty acids [5, 6]. The authors of these studies claimed that the nutritional formulas proposed worked better than traditional nutritional support. More recently, another method using probiotics has been proposed to reduce the infection of necrosis by intestinal bacteria. A study from Hungary [7] demonstrates that Lactobacillus plantarum 299 together with a substrate of oat fiber administered at a dose of 109 organisms for 1 week by nasojejunal tube is effective in reducing pancreatic sepsis and the number of surgical interventions related to pancreatic damage. This study was carried out in a limited number of patients; subsequently, a multicenter Dutch study named PROPATRIA (probiotics prophylaxis in patients with predicted severe acute pancreatitis) was formulated in order to evaluate whether administration of probiotics in a large study group is able to reduce the infective complications in severe acute pancreatitis and this study is still in progress [8]. While waiting for the results of the Dutch trial, an experimental study on the effects of probiotics on acute pancreatitis has been carried out [9]. In this study, a total of 50 rats were randomly divided into five groups. In Group 1 (control rats), no treatment was given, in Group 2 (the sham group), the rats received an intraperitoneal injection of a 20% solution in 0.15 mol/L NaCl twice, at an interval of 1 h; in Group3 (sham and probiotics), the rats were injected with an equal volume of NaCl and were fed with probiotics via a gastric tube once a day for 5 days; in Group 4 (acute pancreatitis and enteral feeding), the rats received an intraperitoneal injection of 250 mg/100 g body weight of L-arginine as a 20% solution in 0.15 mol/L NaCl twice, at an interval of 1 h; and finally, in Group 5 (acute pancreatitis and enteral feeding with probiotics), the same procedure was used as in Group 4 and probiotics were given by gastric tube. All groups were treated for 5 days and at the end of the experiments a midline incision was made in all rats, and the pancreas and the mesenteric lymph nodes were removed for analysis. The mean scores of fibrosis, acinar cell loss, edema, parenchymal necrosis, mononuclear cell infiltration, polymorpho-nuclear leukocyte infiltration, ductal damage and atypical reactive regeneration in the group having acute pancreatitis with enteral feeding with probiotics (Group 5) were significantly lower than in the group having acute pancreatitis with enteral feeding alone (Group 4). Bacterial translocation to the mesenteric lymph nodes occurred in the group with acute pancreatitis and enteral feeding (Group 4), and in the group of rats with acute pancreatitis and enteral feeding with probiotics (Group 5). Four rats with acute pancreatitis and enteral feeding with probiotics had diarrhea and two rats had soft stools for 2 days even if they all recovered. This study was able to demonstrate that enteral feeding with probiotics added can reduce the severity of acute pancreatitis. The study also points out the possible adverse effects of probiotic treatment even if bacterial contamination due to probiotics reported in humans [10] was not found in this study.
References
Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997; 84:1665-9. [More details]
Windsor AC, Kanwar S, Li AG, Barnes E, Guthrie JA, Spark JI, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42:431-5. [More details]
Nakad A, Piessevaux H, Marot JC, Hoang P, Geubel A, Van Steenbergen W, Reynaert M. Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube. Pancreas 1998; 17:187-93. [More details]
De Beaux AC, O'Riordain MG, Ross JA, Jodozi L, Carter DC, Fearon KC. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition 1998; 14:261-5. [More details]
Foitzik T, Eibl G, Schneider P, Wenger FA, Jacobi CA, Buhr HJ. Omega-3 fatty acid supplementation increases anti-inflammatory cytokines and attenuates systemic disease sequelae in experimental pancreatitis. JPEN J Parenter Enteral Nutr 2002; 26:351-6. [More details]
Lasztity N, Hamvas J, Biro L, Nemeth E, Marosvolgyi T, Decsi T, et al. Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis: a prospective randomized clinical trial. Clin Nutr 2005; 24:198-205. [More details]
Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89:1103-7. [More details]
Besselink MG, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]. BMC Surg 2004; 4:12. [More details]
Muftuoglu MA, Isikgor S, Tosun S, Saglam A. Effects of probiotics on the severity of experimental acute pancreatitis. Eur J Clin Nutr. 20057; December 2005. [More details]
Z'Graggen WJ, Fankhauser H, Lammer F, Bregenzer T, Conen D. Pancreatic necrosis infection due to Lactobacillus paracasei in an immunocompetent patient. Pancreatology 2005; 5:108-9. [More details]
| Full text: | PDF format |
| Look up who cited this article |
Keywords Enteral Nutrition; Pancreatitis, Acute Necrotizing; Probiotics
Correspondence
Raffaele Pezzilli
Dipartimento di Medicina Interna
Ospedale Sant'Orsola-Malpighi
Via Massarenti, 9
40138 Bologna
Italy
Phone: +39-051.636.4148
Fax:+39-051.636.4148
E-mail: pezzilli@aosp.bo.it